Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The theoretical bet behind the triple agonist is that a carefully balanced glucagon signal, combined with GLP-1 and GIP, could push energy expenditure upward while the incretin components govern appetite and glucose
The majority of reports of nausea, vomiting and/or diarrhea occurred during dose escalation
For guidance on reading and interpreting COAs, see our peptide testing guide
Compared to tirzepatide: Tirzepatide activates GLP-1 and GIP receptors, achieving roughly 20-22% weight loss
This may contribute to a healthier internal environment, which is the foundation for high-quality milk production
UV exposure
US$ 20.36
US$ 25.23
US$ 25.77
US$ 22.01
US$ 24.54
